This contribution tries to expel the Dunwich Horprovide an academic opportunity for students to specialize ror of ''undimensioned'' tristimulus values from colorimeas colour designers. The objective is to give students an try. I intend to show that tristimulus values have units, and artistic, theore
HOW MUCH DOES INDUSTRY MATTER, REALLY?
β Scribed by ANITA M. McGAHAN; MICHAEL E. PORTER
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 167 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0143-2095
No coin nor oath required. For personal study only.
β¦ Synopsis
In this paper, we examine the importance of year, industry, corporate-parent, and businessspecific effects on the profitability of U.S. public corporations within specific 4-digit SIC categories. Our results indicate that year, industry, corporate-parent, and business-specific effects account for 2 percent, 19 percent, 4 percent, and 32 percent, respectively, of the aggregate variance in profitability. We also find that the importance of the effects differs substantially across broad economic sectors. Industry effects account for a smaller portion of profit variance in manufacturing but a larger portion in lodging/entertainment, services, wholesale/retail trade, and transportation. Across all sectors we find a negative covariance between corporate-parent and industry effects. A detailed analysis suggests that industry, corporate-parent, and business-specific effects are related in complex ways.
π SIMILAR VOLUMES
This paper explores the extent to which differences in the resources allocated to education explain differences in educational access and performance across countries. Crosscountry regression analysis shows that the link between educational access and performance and public education expenditure is
Recent work on the 'size effect' suggests that size-related regularities in asset prices (such as size, leverage, book to market equity, etc.) should not be regarded as anomalies. This paper first clarifies the argument (by showing why the OLS cross-section regression incorporating size-related vari
Adjuvant therapy for patients with melanoma using interferon Ξ± remains controversial despite numerous randomized clinical trials. In the current study, Kirkwood et al. present the results of a biologic companion trial to Intergroup Trial E1690, which compared highβdose and lowβdose interferon Ξ±2b wi